Munir, T, Howard, D orcid.org/0000-0003-3333-9783, McParland, L et al. (10 more authors) (2018) Obinutuzumab as consolidation after chemo-immunotherapy is highly effective in achieving MRD clearance from bone marrow and peripheral blood-Initial results of UK NCRI Phase II/III GALACTIC trial. In: British Journal of Haematology. 58th Annual Scientific Meeting of the British Society for Haematology, 16-18 Apr 2018, Liverpool, UK. Wiley , p. 79.
Metadata
Authors/Creators: |
|
||||||
---|---|---|---|---|---|---|---|
Keywords: | MRD | ||||||
Dates: |
|
||||||
Institution: | The University of Leeds | ||||||
Academic Units: | The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) | ||||||
Funding Information: |
|
||||||
Depositing User: | Symplectic Publications | ||||||
Date Deposited: | 15 May 2018 09:48 | ||||||
Last Modified: | 15 May 2018 09:48 | ||||||
Status: | Published | ||||||
Publisher: | Wiley | ||||||
Identification Number: | https://doi.org/10.1111/bjh.15226 | ||||||
Related URLs: |